Fulgent Genetics, Inc. (NASDAQ: FLGT)
$18.8600
+0.0100 ( +0.48% ) 152.5K
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Market Data
Open
$18.8600
Previous close
$18.8500
Volume
152.5K
Market cap
$576.56M
Day range
$18.3750 - $18.9550
52 week range
$16.5600 - $28.9200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 04, 2024 |
4 | Insider transactions | 1 | Dec 04, 2024 |
4 | Insider transactions | 1 | Dec 04, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |
8-k | 8K-related | 52 | Nov 08, 2024 |
10-q | Quarterly Reports | 87 | Nov 08, 2024 |
4 | Insider transactions | 1 | Nov 05, 2024 |